Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1985
12/18/1985EP0165123A2 Lipophile derivatives of muramyl peptides having macrophage-activating properties, compositions containing them and processes for obtaining them
12/18/1985EP0165120A1 Lymphadenopathy-associated retrovirus adapted to continuous lymphoblastoid-B cell lines capable of continuously producing said retrovirus, and process for preparing the cell lines
12/18/1985EP0165033A2 Conformationally restricted thymopentin-like compounds
12/18/1985EP0164965A2 Lymphotoxin, nucleic acid encoding it, vectors incorporating the nucleic acid and cells transformed therewith, methods of obtaining lymphotoxin, and lymphotoxin neutralizing antibody
12/18/1985EP0164953A2 Preparation of monoclonal antibodies
12/18/1985EP0164876A1 Displacement polynucleotide assay employing recombination protein and diagnostic kit
12/18/1985EP0164719A2 Active site modified protease alpha-1-antitrypsin inhibitors and their production
12/18/1985EP0164654A2 Process for the preparation of peptapeptides acting on the immune system, and their intermediary products
12/18/1985EP0164556A2 Enhanced yeast transcription employing hybrid promoter region constructs
12/17/1985US4559325 Purified antineoplaston fractions and methods of treating neoplastic disease
12/17/1985US4559303 Carrier composed of particulate polymer
12/17/1985US4559230 Protein product, process for making it and pharmaceutical composition containing said protein
12/17/1985CA1198118A1 Derivatives of cycloalka[c]pyrrolcarboxylic acids, a process for their preparation, agents containing these compounds, and their use, and new cycloalka[c]pyrrolcarboxylic acidsas intermediates, and a process for their preparation
12/17/1985CA1198070A1 Water-soluble cross-linked polymer of lysyl endopeptidase, process for preparing same and use of same
12/17/1985CA1198069A1 Temperature sensitive multicopy plasmids
12/17/1985CA1198068A1 Bacterial polypeptide expression employing tryptophan promoter-operator
12/17/1985CA1198067A1 Stable high copy number plasmids
12/17/1985CA1198052A1 Region-specific determinants for vitamin k dependent bone protein
12/17/1985CA1198051A1 Purified glycoproteins from cow, horse and sheep and use in diagnosing infectious mononucleosis
12/11/1985EP0164273A2 New peptide and gene coding for same
12/11/1985EP0164176A2 Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by Eimeria tenella
12/11/1985EP0164069A2 Process for the isolation and purification of alpha-interferons
12/11/1985EP0163993A2 Structure and properties of modified interferons
12/10/1985US4558065 Hypotensive agents
12/10/1985US4558057 Urine extracts
12/10/1985US4558035 Material for use in the treatment of spontaneous abortions
12/10/1985US4558033 Administering deletion peptide
12/10/1985US4558006 Immunoreactive with polypeptide sequence extant of erythropoietin; detecting red blood cell growth stimulating hormone
12/10/1985US4557864 Diuretic acivity
12/10/1985CA1197801A1 Preparation process immunostimulant proteoglycans inductors of interferon, proteoglycans thus obtained and drugs containing them
12/10/1985CA1197797A1 Synthetic urogastrone gene, corresponding plasmid recombinants, transformed cells, production thereof and urogastrone expression
12/10/1985CA1197781A1 Heterotypic canine parvovirus vaccine
12/10/1985CA1197780A1 Production of blood coagulation factor viii:c
12/05/1985WO1985005376A1 Vectors for the expression of factor ix and cell lineages producing the active factor ix
12/04/1985EP0163623A2 The use of a cell surface protein obtained from Staph. aureus
12/04/1985EP0163603A1 A human T-Cell growth factor
12/04/1985EP0163573A1 Site-specific proteolysis by renin
12/04/1985EP0163543A2 Marrow cell stimulator
12/04/1985EP0163529A1 Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors
12/04/1985EP0163493A2 Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
12/04/1985EP0163406A1 Novel polypeptide expression method
12/04/1985EP0163304A2 Human monoclonal antibodies to intermediate filaments
12/04/1985EP0163303A2 Human monoclonal antibodies to cell surface and intracellular antigens
12/04/1985EP0163249A2 Gene-technological process for the preparation of human interleukin-2, and device for carrying out this process
12/04/1985EP0163243A2 Improved human T or B cell lines and a process for producing immunologically active substances using the same
12/04/1985EP0163237A2 Di- and tri-peptidal renin inhibitors
12/04/1985EP0163218A2 Method for the production of human T-T cell hybridomas and production of suppressor factor by human T-T cell hybridomas
12/04/1985EP0163141A2 Monoclonal anti-human IgG antibody and process for preparing the same
12/04/1985EP0163111A2 Method for solubilization of interferon
12/04/1985EP0162977A2 Enzyme immunoassay for cancer procoagulant
12/04/1985EP0162898A1 Interleukin-2 production using cloned genes for interleukin-2 and yeast alpha-factor
12/03/1985US4556655 Antihypertensive compounds having both diuretic and angiotensin converting enzyme inhibitory activity
12/03/1985US4556652 Inhibitors of angiotensin, diuretics, treatment of congestive heart failure
12/03/1985US4556558 Treatment of factor VIII concentrate to minimize the affect of undesirable microorganisms
12/03/1985CA1197481A1 Recombinant dna
12/03/1985CA1197480A1 T cell specific cdna clone
11/1985
11/27/1985EP0162825A2 The use of a specific carcinom associated antigen (hapten), fucosylsialosylgangliotetraose (Fuc-GM1) in diagnostic or therapeutic procedures related to human lung cancer (small cell carcinomas)
11/27/1985EP0162812A2 Lymphokine in the pure state, monoclonal antibodies, hybridoma cell lines, processes and applications
11/27/1985EP0162782A1 Expression vectors for factor IX, and cell lines producing the active factor IX
11/27/1985EP0162757A1 Vaccine for rabies and process for its preparation
11/27/1985EP0162738A1 Production of pseudorabies virus subunit vaccines
11/27/1985EP0162699A2 Interleukin-2 receptor and DNA encoded therefor and their preparation
11/27/1985EP0162639A2 Antigenic preparations and isolation of such preparations
11/27/1985EP0162575A2 GnRH Antagonists VII
11/27/1985EP0162533A2 The detection of human cytomegalovirus specific IgM
11/27/1985EP0162462A2 Purification of type IgM monoclonal antibodies
11/27/1985EP0162422A2 The novel physiologically active substance foroxymithine, a process and microorganisms for its production and its use as medicament
11/27/1985EP0162414A2 Amphipathic peptides and pharmaceutical compositions containing same
11/27/1985EP0162161A1 Cationic oligopeptides having microbicidal activity
11/27/1985EP0162079A1 Use of arg-phe-amide derivatives
11/27/1985EP0162078A1 Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein.
11/26/1985US4555508 Antihypertensive spiro-cyclic compounds
11/26/1985US4555486 Method for using an amino-terminus DNA sequence to synthesize a specific double-stranded DNA
11/26/1985US4555403 Pharmacologically active peptides and medicaments containing the same
11/26/1985CA1197235A1 Enkephalin analogues
11/26/1985CA1197188A1 Protozoal antigen
11/21/1985WO1985005125A1 Vectors for the expression of factor ix, cells transformed by said vectors and process for the preparation of factor ix
11/21/1985WO1985005124A1 Human t-cell growth factor
11/21/1985WO1985005123A1 Diagnostic system for the detection of cytomegalovirus
11/21/1985WO1985005122A1 Rotavirus
11/21/1985WO1985005037A1 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc.
11/21/1985EP0162032A2 Novel atrial peptide
11/21/1985EP0161937A2 Recombinant fusion proteins
11/21/1985EP0161935A2 Method, vectors and transformants for high expression of heterologous polypeptides in yeast
11/21/1985EP0161901A2 Human il-1 cDNA sequences encoding biologically-active human il-1 proteins
11/21/1985EP0161852A2 Grf analogs IV
11/21/1985EP0161640A2 Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
11/21/1985EP0161629A1 Signal peptide for the excretion of polypeptides in Streptomycetes
11/21/1985EP0161588A2 Diamino acid derivatives
11/21/1985EP0161504A1 Production of polypeptides with a human gamma-interferon activity
11/21/1985EP0161468A2 Process for the solid phase synthesis of peptides which contain sulfated tyrosine
11/21/1985EP0161464A2 Polymers based on polyvinylene carbonate and/or polyhydroxymethylene, process for their preparation and their use
11/21/1985EP0161384A2 Human endogenous cancer regulatory factors, method of preparing the same, and pharmaceutical compositions containing the same
11/19/1985US4554101 Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
11/13/1985EP0161188A2 Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
11/13/1985EP0161095A2 Vaccine against urinary infection
11/13/1985EP0161017A1 Peptides
11/13/1985EP0161000A2 Human suppressor factors and method of using them
11/13/1985EP0160988A2 Stable silica-based ether bonded phases for biopolymer separations
11/13/1985EP0160897A2 Monoclonal antibodies, process for preparing them and their use
1 ... 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 2887 2888 2889 2890 ... 2916